Search

Your search keyword '"Rovina, Nikoletta"' showing total 392 results

Search Constraints

Start Over You searched for: Author "Rovina, Nikoletta" Remove constraint Author: "Rovina, Nikoletta"
392 results on '"Rovina, Nikoletta"'

Search Results

52. A Multimodal Approach for the Risk Prediction of Intensive Care and Mortality in Patients with COVID-19

53. Weaning Failure in Critically Ill Patients Is Related to the Persistence of Sepsis Inflammation

56. RELIght: A two‐year REal‐LIfe study of mepolizumab in patients with severe eosinophilic asTHma in Greece: Evaluating the multiple components of response

57. Respiratory microbiome dysbiosis and temporal dynamics in individuals with asthma.

59. Development and validation of SCOPE score: A clinical score to predict COVID-19 pneumonia progression to severe respiratory failure

60. Health-related quality of life in older patients surviving ICU treatment for COVID-19: results from an international observational study of patients older than 70 years

61. The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies

62. The association of the Activities of Daily Living and the outcome of old intensive care patients suffering from COVID-19

63. Noninvasive ventilation in COVID-19 patients aged ≥ 70 years—a prospective multicentre cohort study

64. Development and validation of SCOPE score: a clinical score to predict progression of COVID-19 pneumonia to severe respiratory failure

65. Modified SCOPE (mSCOPE) Score as a Tool to Predict Mortality in COVID-19 Critically Ill Patients.

66. Critically ill COVID-19 patients with obstructive pulmonary diseases: Characteristics, risk factors and outcome.

67. ENaC gene variants and their involvement in Covid‑19 severity.

68. TFEB signaling attenuates NLRP3‐driven inflammatory responses in severe asthma

69. Towards Personalized Immunotherapy in Sepsis: The PROVIDE Randomized Clinical Trial

70. Immunostimulation and Coagulopathy in COVID-19 Compared to Patients With H1N1 Pneumonia or Bacterial Sepsis

72. A Multimodal Approach for the Risk Prediction of Intensive Care and Mortality in Patients with COVID-19

74. Angiotensin-Converting Enzyme 2 (ACE2) As a Novel Biorecognition Element in A Cell-Based Biosensor for the Ultra-Rapid, Ultra-Sensitive Detection of the SARS-CoV-2 S1 Spike Protein Antigen

75. ESCAPE: An Open-Label Trial of Personalized Immunotherapy in Critically lll COVID-19 Patients

78. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

79. X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19

81. Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients

82. COVID-19 ARDS: Points to Be Considered in Mechanical Ventilation and Weaning

83. Management and outcomes in critically ill nonagenarian versus octogenarian patients

84. Unraveling the Relationship of Asthma and COVID-19

85. The impact of frailty on survival in elderly intensive care patients with COVID-19: the COVIP study

88. Capturing patient-centered outcomes using innovative technologies in adults with severe eosinophilic asthma on benralizumab: The EMPOWAIR real-world study design.

89. Lactate is associated with mortality in very old intensive care patients suffering from COVID-19: results from an international observational study of 2860 patients

90. Dual Bronchodilator in the Era of Triple Therapy

91. Unfractionated heparin reduces hepcidin levels in critically ill patients

93. ESCAPE: An Open-Label Trial of Personalized Immunotherapy in Critically Ill COVID-19 Patients

94. Development and Validation of SCOPE Score: A Clinical Score to Predict Progression to Severe Respiratory Failure in Hospitalized Patients With COVID-19 Pneumonia

95. Study of Inflammatory Biomarkers in COPD and Asthma Exacerbations

96. Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison

Catalog

Books, media, physical & digital resources